Literature DB >> 21076288

Cardiovascular implantable electrophysiological device-related infections: a review.

Paul A Gould1, Lorne J Gula, Raymond Yee, Allan C Skanes, George J Klein, Andrew D Krahn.   

Abstract

PURPOSE OF REVIEW: The use of cardiac implantable electrophysiological device (CIED) therapy in the management of cardiac disease is increasing with the improvements in technology of permanent pacemaker and implantable cardioverter defibrillators. Accordingly CIED-related infections are increasing and have become an important clinical problem. The purpose of this review is to summarize current literature on the epidemiology, risk factors, pathophysiology, diagnosis and management of CIED-related infections. RECENT
FINDINGS: The diagnosis and management of CIED-related infections can be difficult. Recent research would suggest extraction of all CIED components, and concomitant appropriate antibiotic therapy is the principal management modality of CIED component and pocket infection. The exact duration of antibiotic therapy and timing of re-implantation still require further delineation in the absence of comparative evidence; however, improvements in technologies such as the excimer laser have enabled percutaneous extraction to be performed effectively and safely in the vast majority of patients. Differentiating CIED-related infection from noninfected mechanical issues that may not require extraction or antibiotics can be very difficult. Research is continuing into better methods to diagnose and treat infection.
SUMMARY: CIED-related infections are an important clinical problem with ongoing research to improve diagnosis and treatment. Currently, percutaneous CIED extraction and antibiotic therapy are the mainstay of treatment.

Entities:  

Mesh:

Year:  2011        PMID: 21076288     DOI: 10.1097/HCO.0b013e328341384e

Source DB:  PubMed          Journal:  Curr Opin Cardiol        ISSN: 0268-4705            Impact factor:   2.161


  5 in total

1.  Combination prophylactic therapy with rifampin increases efficacy against an experimental Staphylococcus epidermidis subcutaneous implant-related infection.

Authors:  Alexandra I Stavrakis; Jared A Niska; Jonathan H Shahbazian; Amanda H Loftin; Romela Irene Ramos; Fabrizio Billi; Kevin P Francis; Michael Otto; Nicholas M Bernthal; Daniel Z Uslan; Lloyd S Miller
Journal:  Antimicrob Agents Chemother       Date:  2014-02-10       Impact factor: 5.191

2.  Risk factors influencing complications of cardiac implantable electronic device implantation: infection, pneumothorax and heart perforation: a nationwide population-based cohort study.

Authors:  Yu-Sheng Lin; Sheng-Ping Hung; Pei-Rung Chen; Chia-Hung Yang; Hung-Ta Wo; Po-Cheng Chang; Chun-Chieh Wang; Chung-Chuan Chou; Ming-Shien Wen; Chang-Ming Chung; Tien-Hsing Chen
Journal:  Medicine (Baltimore)       Date:  2014-12       Impact factor: 1.889

3.  Cardiac implantable electronic device infections: Observational data from a tertiary care center in Lebanon.

Authors:  Marwan Refaat; Patrick Zakka; Maurice Khoury; Hassan Chami; Shareef Mansour; Bernard Harbieh; Bernard Abi-Saleh; Abdul Rahman Bizri
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

Review 4.  Cardiac Implantable Electronic Devices Infection Assessment, Diagnosis and Management: A Review of the Literature.

Authors:  Filippo Toriello; Massimo Saviano; Andrea Faggiano; Domitilla Gentile; Giovanni Provenzale; Alberto Vincenzo Pollina; Elisa Gherbesi; Lucia Barbieri; Stefano Carugo
Journal:  J Clin Med       Date:  2022-10-06       Impact factor: 4.964

Review 5.  Surgical management of superior vena cava syndrome following pacemaker lead infection: a case report and review of the literature.

Authors:  John Kokotsakis; Umar A R Chaudhry; Dimitris Tassopoulos; Leanne Harling; Hutan Ashrafian; Michail Vernandos; Meletis Kanakis; Thanos Athanasiou
Journal:  J Cardiothorac Surg       Date:  2014-06-19       Impact factor: 1.637

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.